Agneta Swedin

410 total citations
15 papers, 258 citations indexed

About

Agneta Swedin is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Agneta Swedin has authored 15 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Agneta Swedin's work include Multiple Myeloma Research and Treatments (8 papers), Eosinophilic Disorders and Syndromes (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Agneta Swedin is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Eosinophilic Disorders and Syndromes (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Agneta Swedin collaborates with scholars based in Sweden, Denmark and United States. Agneta Swedin's co-authors include Tor Olofsson, Bertil Johansson, Carin Lassen, Thoas Fioretos, Rolf Billström, Conny Nordin, Ioannis Panagopoulos, Felix Mitelman, Bodil Strömbeck and Margareth Isaksson and has published in prestigious journals such as Blood, Biological Psychiatry and British Journal of Haematology.

In The Last Decade

Agneta Swedin

15 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Agneta Swedin Sweden	8	163	106	85	69	60	15	258
Arthavan Selvanathan Australia	7	98 0.6×	88 0.8×	21 0.2×	22 0.3×	55 0.9×	22	290
Sabrina Dupont France	6	290 1.8×	300 2.8×	151 1.8×	383 5.6×	24 0.4×	8	536
June Allison-Thacker United States	1	110 0.7×	50 0.5×	40 0.5×	107 1.6×	11 0.2×	2	329
Justine E. Marum Australia	8	45 0.3×	152 1.4×	21 0.2×	35 0.5×	10 0.2×	14	302
Lan Pham United States	7	50 0.3×	109 1.0×	11 0.1×	37 0.5×	36 0.6×	17	217
Frank Fabris United States	9	30 0.2×	112 1.1×	16 0.2×	33 0.5×	18 0.3×	12	269
Fernando Cavalcanti Brazil	9	22 0.1×	87 0.8×	83 1.0×	23 0.3×	9 0.1×	19	247
Bishwa Ghimire Finland	9	74 0.5×	145 1.4×	23 0.3×	77 1.1×	27 0.5×	20	292
Rika Kawagoe Japan	7	37 0.2×	282 2.7×	6 0.1×	59 0.9×	46 0.8×	9	367
Morie A. Gertz United States	4	151 0.9×	166 1.6×	9 0.1×	24 0.3×	80 1.3×	6	251

Countries citing papers authored by Agneta Swedin

Since Specialization

Citations

This map shows the geographic impact of Agneta Swedin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta Swedin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta Swedin more than expected).

Fields of papers citing papers by Agneta Swedin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agneta Swedin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta Swedin. The network helps show where Agneta Swedin may publish in the future.

Co-authorship network of co-authors of Agneta Swedin

This figure shows the co-authorship network connecting the top 25 collaborators of Agneta Swedin. A scholar is included among the top collaborators of Agneta Swedin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agneta Swedin. Agneta Swedin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lund, Johan, Astrid Gruber, Birgitta Lauri, et al.. (2018). Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma. Cancer Medicine. 7(6). 2256–2268. 3 indexed citations

Falk, Ingrid Jakobsen, Johan Lund, Henrik Gréen, et al.. (2017). Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial. Cancer Chemotherapy and Pharmacology. 81(1). 183–193. 12 indexed citations

Hjorth, Martin, Øyvind Hjertner, Lene Meldgaard Knudsen, et al.. (2012). Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study. European Journal Of Haematology. 88(6). 485–496. 41 indexed citations

Nahi, Hareth, Johan Liwing, Johan O. L. Andreasson, et al.. (2012). Is Multiple Myeloma a Chronic Disease? A Population Based Study Comparing 1843 Patients to a Matched Swedish Population.. Blood. 120(21). 2970–2970. 1 indexed citations

Ågerstam, Helena, Henrik Lilljebjörn, Carin Lassen, et al.. (2007). Fusion gene‐mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome. Genes Chromosomes and Cancer. 46(7). 635–643. 41 indexed citations

Fioretos, Thoas, Ioannis Panagopoulos, Carin Lassen, et al.. (2001). Fusion of the BCR and the fibroblast growth factor receptor‐1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL. Genes Chromosomes and Cancer. 32(4). 302–310. 81 indexed citations

Fioretos, Thoas, Ioannis Panagopoulos, Carin Lassen, et al.. (2001). Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder. Lund University Publications (Lund University). 98(11). 558–558. 1 indexed citations

Thunberg, Ulf, Mats Bengtsson, Carsten Geisler, et al.. (1999). Linear reduction of clonal cells in stem cell enriched grafts in transplanted multiple myeloma. British Journal of Haematology. 104(3). 546–552. 11 indexed citations

Swedin, Agneta, Stig Lenhoff, Tor Olofsson, Britt Thuresson, & Jan Westin. (1998). Clinical utility of immunoglobulin heavy chain gene rearrangement identification for tumour cell detection in multiple myeloma. British Journal of Haematology. 103(4). 1145–1151. 19 indexed citations

10.

Thunberg, Ulf, Britt Thuresson, Jan Westin, et al.. (1997). Presence of clonal cells in all stem cell enriched grafts in transplanted multiple myeloma.. Blood. 90. 218. 1 indexed citations

11.

Richter, Jens, et al.. (1995). Aggressive course of primary plasma cell leukemia with unusual morphological and cytogenetic features. Annals of Hematology. 71(6). 307–310. 2 indexed citations

12.

Richter, Johan, et al.. (1995). Aggressive course of primary plasma cell leukemia with unusual morphological and cytogenetic features. Annals of Hematology. 71(6). 307–310. 6 indexed citations

13.

Nordin, Conny, et al.. (1995). Gradients of CSF monoamine metabolites: A comparison between male and female volunteers. Journal of Psychiatric Research. 29(2). 133–140. 22 indexed citations

14.

Nordin, Conny, et al.. (1993). Response. Biological Psychiatry. 33(1). 62–63. 1 indexed citations

15.

Nordin, Conny, et al.. (1993). Tapping-time influences concentrations of 5-HIAA in the CSF. Journal of Psychiatric Research. 27(4). 409–414. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact